Ainos, Inc NT 10-K, filed Apr 3, 2023

Ainos, Inc. (AIMD)

NT 10-K 2023-04-03 For: 2022-12-31

Added on October 17, 2026

☒	(a)	The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense

☒	(b)	The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

☐	(c)	The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

Lawrence K. Lin		858		869-2986
(Name)		(Area Code)		(Telephone number)

Date: March 31, 2023	By:	/s/ Lawrence K. Lin
		Executive Vice President of Operations

	·	Revenues were US$1,038,025 in the fourth quarter of 2022, up 3,832% year over year.
	·	Gross profit was US$459,815, up 2,668% year over year, representing a gross margin of 44.3% in the fourth quarter of 2022.

	·	R&D expenses increased to US$1,798,868 in the fourth quarter of 2022 from US$1,273,847 a year ago. When excluding depreciation and amortization expenses, R&D expenses increased to US$586,224 from US$428,635 over the same period.
	·	SG&A expenses increased to US$787,531 from US$178,194 over the same period. When excluding depreciation and amortization expenses and share-based compensation, SG&A expenses increased to US$538,822 from US$354,295 over the same period.

	·	R&D expenses increased to US$6,845,964 in the full year of 2022 from US$1,920,645 in the same period of 2021. When excluding depreciation and amortization expenses, R&D expenses increased to US$2,134,935 from US$655,706 over the same period.
	·	SG&A expenses increased to US$8,535,591 from US$2,357,163 over the same period. When excluding depreciation and amortization expenses and share-based compensation, SG&A expenses increased to US$2,062,046 from US$1,404,811 over the same period.

Ainos, Inc.
Condensed Consolidated Statements of Operations

	Three months ended December 31						Twelve months ended December 31
	2022			2021			2022			2021
Revenues	$	1,038,025		$	26,399		$	3,519,627		$	594,563
Cost of revenues		(578,210	)		(9,786	)		(2,114,284	)		(184,181	)
Gross Profit		459,815			16,613			1,405,343			410,382
Operating expenses:
Research and development expenses		1,798,868			1,273,847			6,845,964			1,920,645
Selling, General and administrative expenses		787,531			178,194			8,535,591			2,357,163
Total operating expenses		2,586,399			1,452,041			15,381,555			4,277,808
Operating loss		(2,126,584	)		(1,435,428	)		(13,976,212	)		(3,867,426	)
Non-operating income and expenses, net
Interest expenses, net		(8,224	)		(9,328	)		(53,528	)		(18,689	)
Other income (losses), net		3,800			(15	)		23,050			(2,547	)
Total non-operating income and expenses, net		(4,424	)		(9,343	)		(30,478	)		(21,236	)
Net loss		(2,131,008	)		(1,444,770	)		(14,006,690	)		(3,888,661	)

Net loss per common shares-basic and diluted	$	(0.11	)	$	(0.15	)	$	(1.03	)	$	(0.51	)

Weighted average common shares outstanding- basic and diluted		19,866,674			9,501,762			13,637,292			7,551,360

Ainos, Inc. Condensed Consolidated Balance Sheets (Unaudited)

	December 31, 2022			December 31, 2021
Assets
Current assets:
Cash and cash equivalents	$	1,853,362		$	1,751,499
Accounts receivable		201,546			-
Inventory		595,222			-
Other current assets		195,787			466,198
Total current assets		2,845,917			2,217,697
Intangible assets, net		32,806,738			37,329,191
Property and equipment, net		1,375,676			1,187,702
Other Assets		80,683			87,571
Total assets	$	37,109,014		$	40,822,161

Liabilities and Stockholders' Equity
Current liabilities:
Convertible notes payable		376,526			3,376,526
Notes payable		884,000			213,405
Accrued expenses and others current liabilities		1,212,386			1,004,868
Payable -related party		-			26,000,000
Total current liabilities		2,472,912			30,594,799
Long term liabilities:
Operating lease liabilities-non-current		8,096			30,255
Total liabilities		2,481,008			30,625,054

Stockholders' equity
Preferred stock, $0.01 par value; 10,000,000 shares authorized; none issued		-			-
Common stock, $0.01 par value;
300,000,000 shares authorized as of Dec 31, 2022 and December 31,2021;
20,011,602 shares and 9,625,133 shares issued and outstanding as of Dec 31, 2022 and December 31, 2021		200,116			96,251
Additional paid-in capital		58,745,149			20,203,972
Accumulated deficit		(24,115,606	)		(10,108,916	)
Translation adjustment		(201,653	)		5,800
Total stockholders' equity		34,628,006			10,197,107
Total liabilities and stockholders' equity	$	37,109,014		$	40,822,161